Discover a study examining the safety and effectiveness of direct drug provocation testing for suspected beta-lactam allergies in children.

Bristol Myers Squibb has appointed Dr Cristian Massacesi as Executive Vice President, Chief Medical Officer and Head of Development.

New research explores the role of the microbiome in acne treatment, focusing on probiotics, prebiotics, and synbiotics as promising therapies with potential to reduce side effects and improve outcomes ...

Deep learning using multimodal MRI can distinguish Parkinson’s disease from multiple system atrophy with high accuracy, offering a promising diagnostic tool for clinical use.

One dose of the HPV vaccine in girls aged 9–14 triggers strong, lasting immune responses, comparable to a full three-dose course in adult women.

Featuring exclusive coverage of the EHA 2025 Congress, uncover industry insights from leading experts, the current treatment landscape for ...

Discover what's new in Rheumatology in our new issue, featuring coverage on psoriatic arthritis and axial spondyloarthritis, giant cell ...

Urine VOCs are linked to COPD risk and inflammation in NHANES data, suggesting potential for non-invasive screening with strong diagnostic accuracy.

Hema Now | Episode 22 In this episode, host Jonathan Sackier is joined by Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London. From leading the UK’s first adult stem cell ...

Dermoscopy traits of adnexal tumors in skin of color often mimic malignancy, complicating diagnosis and management. Brown blotches and arborizing vessels can mask key clinical distinctions.

Maintaining an INR between 2.5–3.5 significantly reduces the risk of recurrent arterial thrombosis in primary APS patients, highlighting the importance of anticoagulation intensity.